ARCHIVES

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

In Brief: Community Outreach Planning Grants Still Open; Study Section Meetings May Be Opened By Courts

October 18, 1974

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987